CELEX 02008R1272 · v20250901

Article 36 / Harmonisation of classification and labelling of substances

Article 36

Harmonisation of classification and labelling of substances

1.  

A substance that fulfils the criteria set out in Annex I for the following shall normally be subject to harmonised classification and labelling in accordance with Article 37:

▼M36

(a) 

respiratory sensitisation, category 1, 1A or 1B (Annex I, section 3.4);

▼B

(b) 

germ cell mutagenicity, category 1A, 1B or 2 (Annex I, section 3.5);

(c) 

carcinogenicity, category 1A, 1B or 2 (Annex I, section 3.6);

(d) 

reproductive toxicity, category 1A, 1B or 2 (Annex I, section 3.7);

▼M36

(e) 

endocrine disruption for human health, category 1 or 2 (Annex I, section 3.11);

(f) 

endocrine disruption for the environment, category 1 or 2 (Annex I, section 4.2);

(g) 

persistent, bioaccumulative and toxic (Annex I, section 4.3);

(h) 

very persistent, very bioaccumulative (Annex I, section 4.3);

(i) 

persistent, mobile and toxic (Annex I, section 4.4);

(j) 

very persistent, very mobile (Annex I, section 4.4).

▼M36

2.  
Substances that are active substances falling within the scope of Regulation (EC) No 1107/2009 or Regulation (EU) No 528/2012 shall be subject to harmonised classification and labelling. For such substances, the procedures set out in Article 37(1), (4), (5) and (6) shall apply.

▼B

3.  
Where a substance fulfils the criteria for other hazard classes or differentiations than those referred to in paragraph 1 and does not fall under paragraph 2, a harmonised classification and labelling in accordance with Article 37 may also be added to Annex VI on a case-by-case basis, if justification is provided demonstrating the need for such action at Community level.

Source: Content sourced from EUR-Lex and licensed under CC BY 4.0. This is an unofficial presentation; only the official EUR-Lex version is legally authentic.

Screen documents for chemicals